Table 8. In vivo activity of Abbott quinobenoxazine 56 against human tumor xenographs.

Tumor	Treatment route and schedule	Dose (mg/kg)	Best % TWIa	Cures (%)
CX-1 colon	i.p. QD D2-11	20	79	*
MBA 9812 mammary	i.p. QD D2-11	20	76	*
LX-1 lung	i.p. QD D2-11	20	43	*
MX-1 mammary	i.v. Q4Dx3	40	84	30
HT29 colon	i.v. Q4Dx3	40	21	*

^aTumor weight inhibition; *data not reported.